Research & Development
The improved oil deodorising process commissioned at Altona in 2006 provides refined tuna oil to meet the exacting requirements of our customers around the world. The high quality refined tuna oil is also used in the preparation of microencapsulated powders.
Nu-Mega utilises a number of patented encapsulation technologies to prepare its range of powdered omega-3 oil products. Nu-Mega has a long-standing and ongoing association with Food Science Australia and CSIRO to develop encapsulation technologies. These powdered ingredients are marketed under the Driphorm® and ThermoMAX® trade marks.
Clover Corporation Limited participates and/or provides its products for use in a variety of nutritional and clinical studies which are being conducted around the world. The results of these scientific studies are routinely published in peer reviewed journals.
Nu-Mega is a foundation member of both the Omega-3 Centre in Australia and GOED (The Global Organisation for EPA and DHA Omega-3) in North America. The primary focus of both groups is to improve and enhance the positive communication of omega-3 oils to all sections of the community.
Nu-Mega is actively involved in the obtaining approval for the use of its products in target markets, seeking approval for claims related to health benefits of long chain Omega-3 oils and DHA, and continually advancing the discussion related to the benefits of long chain Omega-3 oils and DHA.
Clover actively pursues the development and commercialization of products that focus on the delivery of bioactive nutrients. These products are designed for use in many applications including infant formula, children’s foods, functional foods, medical foods and pharmaceuticals.